Corcept Therapeutics
CORT
#2296
Rank
HK$64.38 B
Marketcap
HK$588.30
Share price
3.10%
Change (1 day)
0.21%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2023 (TTM): HK$6.89

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is HK$4.08. In 2022 the company made an earnings per share (EPS) of HK$7.45 a decrease over its 2021 EPS that were of HK$7.61.

EPS history for Corcept Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$6.89-7.47%
2022HK$7.45-2.06%
2021HK$7.615.43%
2020HK$7.2110.84%
2019HK$6.5127.69%
2018HK$5.10-42.48%
2017HK$8.861518.29%
2016HK$0.55-199.75%
2015-HK$0.55-77.42%
2014-HK$2.43-32.61%
2013-HK$3.6112.2%
2012-HK$3.212.5%
2011-HK$3.142.56%
2010-HK$3.062.63%
2009-HK$2.98-11.63%
2008-HK$3.3726.47%
2007-HK$2.67-68.81%
2006-HK$8.5523.86%
2005-HK$6.90-1.12%
2004-HK$6.98-27.05%
2003-HK$9.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.42 1,185.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.17 909.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.03 5,835.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78 90.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.44 769.23%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-HK$1.02-125.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.16-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$2.98-26.92%๐Ÿ‡บ๐Ÿ‡ธ USA